Ipsen SA (IPSEF) reports robust financial performance with a 9.9% sales increase and strategic pipeline developments, despite ...

Standing out in an oversaturated market requires a combination of self-awareness, adaptability and strategic action.

On the revenue side, PBMs get paid by insurance companies to secure rebates from drugmakers in exchange for favorable ...

Malaysia has long positioned itself as a global leader in halal tourism, offering a range of Muslim-friendly services and experiences. With its rich Islamic heritage, world-class halal-certified ...

In the marketing and comms space, this is one of the most important, ongoing conversations taking place. The question isn’t ...

Zoetis is the undisputed leader in the global animal health industry, and we believe it possesses the widest moat of all the competitors. Zoetis has set itself apart based on its impressive innovation ...

The real challenge isn't in which technologies to adopt, but in identifying how to extract the most value from investments.

Ipsen expects total sales growth of more than 5% at constant exchange rates in 2025, supported by the continued expansion of products like IQIRVO, ONIVYDE, and Bylvay. However, Somatuline faces ...

The recent earnings reports for Chili’s and McDonald’s highlight the shifting dynamics in the restaurant industry. While ...

Does the EU’s pharma patent system balance innovation and access—or block competition? Join POLITICO’s Oxford-style debate as two teams go head-to-head on this high-stakes issue. Have your ...

Market OverviewThe Orphan Drugs Market is a specialized sector within the pharmaceutical industry that focuses on the ...

India's public sector general insurance companies (PSGICs) achieved a financial turnaround in Q3 of 2024-25, posting a ...